BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7680194)

  • 1. Mammary Paget's disease and associated carcinoma. An immunohistochemical study.
    Cohen C; Guarner J; DeRose PB
    Arch Pathol Lab Med; 1993 Mar; 117(3):291-4. PubMed ID: 7680194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
    Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
    Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100 protein in human mammary tissue--immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cells.
    Gillett CE; Bobrow LG; Millis RR
    J Pathol; 1990 Jan; 160(1):19-24. PubMed ID: 2156036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and immunohistochemical observations on the mammary and extramammary Paget's disease: implications for the histogenesis.
    Filotico R; De Santis M; Filotico M
    Pathologica; 1992; 84(1091):275-85. PubMed ID: 1281536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An immunohistochemical analysis of extramammary Paget's disease compared with mammary Paget's disease].
    Hasebe T; Yamamichi N; Konishi F; Mukawa A
    Gan No Rinsho; 1988 Feb; 34(2):159-66. PubMed ID: 2831411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Associated Paget's disease of the vulva and of the nipple in the same patient: pathology with ultrastructural study (author's transl)].
    Fetissoff F; Arbeille-Brassart B; Lansac J; Sam-Giao M; Granger M; Lorette G
    Ann Dermatol Venereol; 1982; 109(1):43-50. PubMed ID: 6280570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical studies of breast and extra-mammary Paget's disease indicate an apocrine differentiation].
    Lautier R; Achtelik WV; Wolff HH
    Z Hautkr; 1990 Jun; 65(6):571-4. PubMed ID: 2167569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
    Meissner K; Rivière A; Haupt G; Löning T
    Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description.
    Marucci G; Betts CM; Golouh R; Peterse JL; Foschini MP; Eusebi V
    Virchows Arch; 2002 Aug; 441(2):117-23. PubMed ID: 12189500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ras p21 in mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Nakano S; Sasai Y; Shiku H
    Arch Pathol Lab Med; 1990 Aug; 114(8):858-61. PubMed ID: 1695839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
    Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
    Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological evidence for field effect as a mechanism for tumour spread in mammary Paget's disease.
    Mai KT
    Histopathology; 1999 Dec; 35(6):567-76. PubMed ID: 10583581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinar pattern of mammary Paget's disease: a case report.
    Barnes PJ; Dumont RJ; Higgins HG
    Breast J; 2007; 13(5):520-6. PubMed ID: 17760678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein expression in mammary and extramammary Paget's disease.
    Kanitakis J; Thivolet J; Claudy A
    Anticancer Res; 1993; 13(6B):2429-33. PubMed ID: 8135479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pigmented Paget's disease of the male nipple].
    Menet E; Vabres P; Brecheteau P; Bonneau-Herve F; Duport G; Levillain P; Larregue M; Babin P
    Ann Dermatol Venereol; 2001 May; 128(5):649-52. PubMed ID: 11427802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
    Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
    Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary and extramammary Paget's disease. An immunocytochemical and ultrastructural study.
    Ordóñez NG; Awalt H; Mackay B
    Cancer; 1987 Mar; 59(6):1173-83. PubMed ID: 2434206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease.
    Battles OE; Page DL; Johnson JE
    Am J Clin Pathol; 1997 Jul; 108(1):6-12. PubMed ID: 9208972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.